“…Recently, quantified DAPs and MAPs in urine have been identified as biomarkers to assess human exposure. In total, DAPs of BDCIPP, BCIPP, BCEP, BBOEP, DBP, DPHP, DEHP and some MAPs of MEHP, MBP, MCIPP, MBOEP and MPHP have been quantified in human urine, with median concentrations in the ng ml À1 range (Butt et al, 2014;Cequier et al, 2014bCequier et al, , 2015Chu et al, 2011;Cooper et al, 2011;Dodson et al, 2014;Fromme et al, 2014;Hoffman et al, 2015;Meeker et al, 2013a,b;Moller et al, 2004;Petropoulou et al, 2016;Reemtsma et al, 2011;Schindler et al, 2009a,b;Van den Eede et al, 2015b;Van den Eede et al, 2013b) (SI Table S2). However, no information is available for DAPs and MAPs or other OPFR metabolites from internal exposure studies of wild animals.…”